TrialAnnals of nuclear medicine2018

Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial.

Michael J Seider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.